PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15567100-7	2004	Interleukin-2 (IL-2) production of infected cells was completely inhibited by DFO and excess iron while stress protein (Hsp70) levels were lowered in the presence of HIV in combination with excess iron (37%, P<0.01) or DFO (47.2%, P<0.01) when compared to untreated cells.	Deferoxamine	78-81	interleukin 2	Homo sapiens	0-13	
15567100-7	2004	Interleukin-2 (IL-2) production of infected cells was completely inhibited by DFO and excess iron while stress protein (Hsp70) levels were lowered in the presence of HIV in combination with excess iron (37%, P<0.01) or DFO (47.2%, P<0.01) when compared to untreated cells.	Deferoxamine	222-225	interleukin 2	Homo sapiens	0-13	
15567100-7	2004	Interleukin-2 (IL-2) production of infected cells was completely inhibited by DFO and excess iron while stress protein (Hsp70) levels were lowered in the presence of HIV in combination with excess iron (37%, P<0.01) or DFO (47.2%, P<0.01) when compared to untreated cells.	Deferoxamine	78-81	interleukin 2	Homo sapiens	15-19	
3127348-4	1987	IL-2 production by mitogen-stimulated T4+T8- and T8+T4- populations is also markedly reduced by desferroxamine treatment.	Deferoxamine	96-110	interleukin 2	Homo sapiens	0-4	
8932291-3	1996	The immunomodulatory effects of DFO/DTPA seem to be due to the impaired expression of interleukin-2 receptor and the reduced secretion of interleukin-2.	Deferoxamine	32-35	interleukin 2	Homo sapiens	86-99	
8932291-3	1996	The immunomodulatory effects of DFO/DTPA seem to be due to the impaired expression of interleukin-2 receptor and the reduced secretion of interleukin-2.	Deferoxamine	32-35	interleukin 2	Homo sapiens	138-151	
2228020-2	1990	The present study investigated whether desferrioxamine operates late in the activation process or, as recently suggested, at an early stage, by inhibiting the appearance of the interleukin-2 (IL-2) receptor.	Deferoxamine	39-54	interleukin 2	Homo sapiens	177-190	
2228020-5	1990	300 mumol/l desferrioxamine present throughout culture abrogated [3H]TdR incorporation and additionally suppressed IL-2 receptor to 10-15% of control levels.	Deferoxamine	12-27	interleukin 2	Homo sapiens	115-119